Meticulous Market Research reports: According to a new market research report, “Ambulatory EHR Market Size, Share, Forecast, & Trends Analysis by Deployment Mode (Cloud, On-premise) Type (All-in-one, Modular) Application (Practice, Patient Portal, CPOE, CDS, Referral, Population Health) End User, Practice — Global Forecast to 2031,” published by Meticulous Research, the ambulatory EHR market is expected to reach $7.84 billion by 2031, at a CAGR of 5.3% from 2024 to 2031.

Download Sample Report Now

Ambulatory electronic health record (EHR) software is designed for outpatient care settings, enabling medical professionals to access a patient’s complete medical history stored in an electronic format. This data includes records of treatments and procedures conducted outside of hospital admissions. Ambulatory EHR systems facilitate easier monitoring of a patient’s medical history and long-term care by physicians. Through this software, physicians can gather detailed and relevant information about each patient, resulting in comprehensive personal health records. This extensive database helps doctors gain a deeper understanding of a patient’s health, thereby simplifying potential diagnoses.

The growth of the ambulatory EHR market is driven by supportive government initiatives aimed at promoting EHR adoption, the rising preference for ambulatory care over in-patient services among patients, and the rising need to reduce operational costs in the healthcare sector. Additionally, the integration of artificial intelligence (AI) and machine learning (ML) technologies with ambulatory EHRs and the evolving technological landscape in developing countries are expected to create market growth opportunities. However, IT infrastructure constraints in developing nations, concerns about data security, and high implementation costs may restrain market growth.

The report also includes an extensive assessment of leading players’ product portfolios and geographic presence and the key growth strategies adopted by them over the past three to four years. In recent years, the ambulatory EHR market has witnessed several organic and inorganic strategic developments. The key players profiled in the ambulatory EHR market report are Epic Systems Corporation (U.S.), Cerner Corporation (U.S.), Medical Information Technology, Inc. (U.S.), Computer Programs and Systems, Inc. (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), athenahealth, Inc. (U.S.), NextGen Healthcare, Inc (U.S.), eClinicalWorks (U.S.), Greenway Health, LLC (U.S.), CureMD Healthcare (US), and AdvancedMD, Inc. (U.S.).

Get a Glimpse Inside: Request Sample Pages- https://www.meticulousresearch.com/request-sample-report/cp_id=5190

Rising Need to Reduce Operating Costs in the Healthcare Sector Driving Market Growth

Many hospitals and health systems are currently dealing with escalating operating costs. Electronic health records are known to improve the efficiency of medical practice. Operating costs can be reduced by lowering transcription costs, reducing time spent on documentation, improving documentation for billing, and limiting or eliminating chart pull, storage, and re-filing costs. Studies indicate that adopting EHRs can result in significant cost savings. Hospitals and practices leveraging EHR software can effectively manage expenditures. For instance, data published in the American Journal of Managed Care suggests that patients admitted to hospitals with EHRs may pay up to USD 730 less than those admitted to hospitals without EHRs, primarily due to enhanced efficiency.

Additionally, substantial financial losses are incurred due to medical errors, encompassing expenses for patients requiring treatment to recover from such errors and the high costs of malpractice lawsuits. According to the Commonwealth Fund, medical errors are estimated to cost between USD 17 billion to USD 29 billion annually. The implementation of EHRs can play a pivotal role in reducing these costs by minimizing errors.

The ambulatory EHR market is segmented by Deployment Mode (Cloud/Web-based Ambulatory EHR, On-premise Ambulatory EHR), Type (All-in-one Ambulatory EHR, Modular Ambulatory EHR), Practice Size (Large Practices, Small to Medium-sized Practices, Solo Practices), Application (Practice Management, Computerized Physician Order Entry (CPOE), Patient Portals, Clinical Decision Support (CDS), Referral Management, and Other Applications), End User (Hospital-owned Ambulatory Centers, Independent Ambulatory Centers), and Geography.

Among the deployment modes covered in this report, in 2024, the cloud/web-based ambulatory EHR segment is expected to account for the larger share of 77.5% of the ambulatory EHR market. This segment’s large market share can be attributed to the advantages of cloud-based deployments, including flexibility, real-time monitoring, data security, and lower implementation costs compared to on-premise deployments. Some of the key companies offering cloud/web-based ambulatory EHRs are Epic Systems Corporation (U.S.), Cerner Corporation (U.S.), Medical Information Technology, Inc. (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), Greenway Health, LLC (U.S.), eClinicalWorks (U.S.), and CureMD Healthcare (U.S.).

Have Specific Research Needs? Request a Customized Report

Among the types covered in this report, in 2024, the all-in-one ambulatory EHR segment is expected to account for the larger share of the market. This segment’s large market share can be attributed to the benefits offered by all-in-one ambulatory EHRs, such as ease of use, comprehensive functionalities, absence of compatibility issues, and seamless integration of software and hardware.

Among the practice sizes covered in this report, in 2024, the large practices segment is expected to account for the largest share of the market. Large practices are typically conducted within sizable organizations housing over 50-100 physicians. This segment’s large market share can be attributed to the rising need for efficient administration and coordination within such extensive setups and equitable distribution of costs and tasks among staff. Moreover, the acquisition of smaller ambulatory surgical centers by larger players contributes to the segment’s significant market share. For instance, in October 2023, SurgNet Health Partners, Inc. (U.S.) announced the acquisitions of Executive Ambulatory Surgery Center (U.S.) and Lippy Surgery Center (U.S.).

Among the applications covered in this report, in 2024, the practice management segment is expected to account for the largest share of 25.9% of the market. Practice management typically encompasses appointment scheduling, patient demographics, visual resource planning, document management, billing, and claim management—all essential components utilized in the daily operations of ambulatory practices. This segment’s large market share can be attributed to factors such as the widespread adoption by ambulatory surgical centers, primarily due to the advanced features offered by these EHRs, including efficient patient scheduling and streamlined management of billings and claims.

Among the end users covered in this report, in 2024, the hospital-owned ambulatory centers segment is expected to account for the larger share of the market. Hospital-owned ambulatory centers, integrated within hospitals, represent a prevalent clinical model in integrated healthcare systems. This segment’s large market share can be attributed to the robust financial capabilities of these centers, facilitating significant investments in advanced EHRs and the benefits offered by these EHRs, including improved coordination of patients’ medical records and adherence to higher patient safety and quality guidelines. Additionally, the increasing need to streamline unstructured healthcare data further drives the adoption of ambulatory EHRs within these centers.

Geographically, in 2024, North America is expected to account for the largest share of 51.2% of the ambulatory EHR market, followed by Europe and Asia-Pacific. North America’s significant market share can be attributed to factors such as the proliferation of ambulatory surgery centers and the presence of leading EHR providers within the region. Furthermore, supportive government initiatives aimed at promoting EHR adoption contribute to the growth of this regional market. For instance, Canada Health Infoway (CHI) has launched initiatives to promote the adoption and utilization of EHR systems. It aims to establish a national infrastructure that facilitates the sharing of EHR systems across Canada.

However, the Asia-Pacific ambulatory HER market is projected to register the highest CAGR during the forecast period.

Scope of the Report:

Ambulatory EHR Market—by Deployment Mode

• Cloud/Web-based Ambulatory EHR
• On-premise Ambulatory EHR

Ambulatory EHR Market—by Type

• All-in-one Ambulatory EHR
• Modular Ambulatory EHR

Ambulatory EHR Market—by Practice Size

• Large Practices
• Small-to-medium-sized Practices
• Solo Practices

Ambulatory EHR Market—by Application

• Practice Management
• Patient Portals
• Computerized Physician Order Entry (CPOE)
• Clinical Decision Support (CDS)
• Population Health Management
• Referral Management
• Other Applications

(Other applications include mobile solutions, health analytics, billing solutions, and telehealth)

Ambulatory EHR Market—by End User

• Hospital-owned Ambulatory Centres
• Independent Ambulatory Centres

Ambulatory EHR Market—by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Denmark
  • Netherlands
  • Sweden
  • Ireland
  • Belgium
  • Rest of Europe (RoE)

• Asia Pacific
  • China
  • Japan
  • India
  • Rest of APAC (RoAPAC)
• Latin America
• Middle East & Africa

Unlock Opportunities: Buy Now- https://www.meticulousresearch.com/Checkout/22865064

Related Reports:

Mid-revenue Cycle Management/ Clinical Documentation Improvement Market by Product & Service [Solutions (Coding, Charge Capture, DRG Group, Pre-Bill Review), Consulting Services], End User (Providers, Payers), and Geography – Global Forecast to 2027

Healthcare Analytics Market by Type (Predictive, Prescriptive), Component (Hardware, Software, and Services), Delivery Mode (Cloud), Application (Clinical, RCM, Claims, Fraud, Risk, PHM), End user (Payer, Provider) and Geography- Global Forecast to 2027

Healthcare Artificial Intelligence Market by Product and Services (Software, Services), Technology (Machine Learning, NLP), Application (Medical Imaging, Precision Medicine, Patient Management), End User (Hospitals, Patients) — Global Forecast to 2027

DelveInsight’s Carotid Artery Stent Market Insights report provides the current and forecast market analysis, individual leading carotid artery stent companies’ market shares, challenges, carotid artery stent market drivers, barriers, trends, and key market carotid artery stent companies in the market.

Key Takeaways from the Carotid Artery Stent Market Report

• As per DelveInsight estimates, North America is anticipated to dominate the global carotid artery stent market during the forecast period.
• In the product type segment of the carotid artery stents market, the self-expanding stents category had a significant revenue share in the year 2023. This can be attributed to the various applications and advantages associated with the self-expanding stents such as self-expanding stents adapt to the anatomy of the carotid area.
• Notable carotid artery stent companies such as Boston Scientific Corporation, Cordis, Balton, Medtronic, Terumo Europe NV, Silk Road Medical Inc., InspireMD Inc., and several others, are currently operating in the carotid artery stent market.
• In October 2023, Boston Scientific Corporation got approval for its Carotid WALLSTENT® Monorail® from USFDA for the treatment of carotid artery disease.
• In October 2022, Cordis a leader in the development and manufacturing of interventional cardiovascular and endovascular technologies, acquired MedAlliance.

To read more about the latest highlights related to the carotid artery stent market, get a snapshot of the key highlights entailed in the Global Carotid Artery Stent Market Report

Carotid Artery Stent Overview

Carotid artery stenting is a minimally invasive procedure used to treat carotid artery disease, a condition where the carotid arteries, located in the neck, become narrowed or blocked by the buildup of plaque. During the procedure, a slender tube called a catheter is inserted into an artery, usually in the groin, and guided to the carotid artery under X-ray imaging. Once in place, a stent—a small mesh tube—is expanded within the narrowed portion of the artery, pushing aside the plaque and restoring blood flow to the brain. This technique is an alternative to carotid endarterectomy, a surgical procedure that involves opening the carotid artery and removing the plaque.

While carotid artery stenting is less invasive compared to surgery, it’s not without risks. Complications can include stroke, bleeding at the puncture site, or the formation of blood clots. However, for certain patients, such as those deemed high-risk for surgery due to other health conditions, or those with difficult-to-reach blockages, carotid artery stenting can be a valuable treatment option. It offers a shorter recovery time and avoids the need for general anesthesia, making it a preferred choice for some individuals. Close monitoring and careful patient selection are crucial to ensure the best possible outcomes.

Carotid Artery Stent Market Insights

In 2023, North America dominated the carotid artery stents market, mainly due to the increasing incidence of cardiovascular diseases and associated risk factors like obesity, hypertension, and diabetes. Factors like government initiatives, high disposable income, a growing aging population, and advanced healthcare facilities further drive market growth in the region.

According to the Centers for Disease Control and Prevention (CDC) in 2022, around 18.2 million adults in the US suffer from coronary artery disease, with approximately 805,000 experiencing heart attacks annually, a significant portion being first-time occurrences. Moreover, the elderly population, especially those over 50, are particularly susceptible to carotid artery disease due to age-related arterial changes.

The United States Census Bureau’s 2021 report indicates that over 54 million adults aged 65 and older lived in the US, and this demographic is expected to reach 85.7 million by 2050, constituting about 20% of the total population. This aging population contributes to the rising demand for carotid artery stents.

Furthermore, the presence of major industry players like Boston Scientific Corporation, Cordis, and Silk Road Medical Inc. headquartered in North America also bolsters the carotid artery stent market growth in the region. Consequently, the increasing prevalence of cardiovascular diseases and the concentration of key market players are driving the expansion of the carotid artery stent market in North America.

To know more about why North America is leading the market growth in the carotid artery stent market, get a snapshot of the Carotid Artery Stent Market Outlook 

Carotid Artery Stent Market Dynamics

The carotid artery stent market has seen significant dynamics over the past few years, driven by a combination of technological advancements, evolving healthcare policies, and increasing prevalence of carotid artery diseases. Carotid artery stenting has emerged as a minimally invasive alternative to traditional surgical interventions for treating carotid artery stenosis, offering reduced recovery times and fewer complications for patients. As a result, the demand for carotid artery stents has been steadily increasing, particularly among aging populations where vascular diseases are more prevalent.

One of the key drivers shaping the carotid artery stent market dynamics is the growing adoption of endovascular procedures by healthcare providers. With advancements in stent design, materials, and delivery systems, carotid artery stenting has become safer and more effective, leading to its wider acceptance as a treatment option. Moreover, the rise in awareness campaigns about stroke prevention and early detection of carotid artery diseases has further fueled the demand for stenting procedures.

However, despite these advancements, challenges persist in the carotid artery stent market. Issues such as stent thrombosis, restenosis, and embolization remain concerns, necessitating ongoing research and development efforts to improve stent design and minimize complications. Additionally, regulatory hurdles and reimbursement policies can impact carotid artery stent market growth, influencing the adoption rates of carotid artery stenting procedures in different regions.

Looking ahead, the carotid artery stent market is poised for continued growth, driven by factors such as an aging population, increasing prevalence of vascular diseases, and ongoing innovations in stent technology. With a focus on improving patient outcomes and reducing procedural risks, manufacturers and healthcare providers are likely to invest further in research, development, and training initiatives to expand the accessibility and efficacy of carotid artery stenting procedures.

Get a sneak peek at the carotid artery stent market dynamics @ Carotid Artery Stent Market Dynamics Analysis

Carotid Artery Stent Market Assessment

• Carotid Artery Stent Market Segmentation
  • Carotid Artery Stent Market Segmentation By Product Type: Self-Expanding Stents, Balloon Expandable Stents, and Others
  • Carotid Artery Stent Market Segmentation By End User: Hospitals & Clinics, Ambulatory Surgical Centers, and Cardiac Centers
  • Carotid Artery Stent Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the carotid artery stent market are set to emerge as the trendsetter explore @ Carotid Artery Stent Companies

Table of Contents 

Interested in knowing the carotid artery stent market by 2030? Click to get a snapshot of the Carotid Artery Stent Market Trends

Related Reports

Ischemic Stroke Pipeline

Ischemic Stroke Pipeline Insight – 2024 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key Ischemic Stroke companies, including Athersys, Inc., Tarveda Therapeutics, Lumosa Therapeutics, NC Medial Research Inc, Acticor Biotech, Meridigen Biotech Co., Prolong Pharmaceuticals, Nanjing Yoko Biomedical Co., Ltd., TrueBinding, Inc., GNT Pharma, Roche, DiaMedica Therapeutics Inc, aptaTargets, Bristol-Myers Squibb, NuvOX Pharma, Simcere Pharmaceutical Co., Ltd., Genentech, Inc., NoNO Inc., Pharming Technologies B.V., Biogen, Avilex Pharma, SanBio, ZZ Biotech, Revalesio, Stemedica Cell Technologies, StemCyte, Ninnion, Algernon Pharmaceuticals, Primary Peptides, TMS, Tasly Pharmaceutical, Pharmazz, among others.

Ischemic Stroke Epidemiology

Ischemic Stroke Epidemiology Forecast – 2032 report delivers an in-depth understanding of the disease, historical, and forecasted ischemic stroke epidemiology in the 7MM.

Acute Ischemic Stroke Market

Acute Ischemic Stroke Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key acute ischemic stroke companies, including Acticor Biotech, DiaMedica Therapeutics, Lumosa Therapeutics, Bristol Myers Squibb, Janssen Pharmaceutical, Genentech, Inc., Athersy, Healios K.K., NoNO Inc., Bayer, ZZ Biotech, Biogen Inc., Revalesio Corporation, AbbVie, TrueBinding, Inc, Silver Creek Pharmaceuticals, among others.

Acute Ischemic Stroke Pipeline

Acute Ischemic Stroke Pipeline Insight – 2024 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key acute ischemic stroke companies, including Genentech, Acticor Biotech, DiaMedica Therapeutics, and NoNO, among others.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “AI Based Wound Care Software Market”- by Types of Service(s) Offered (Isolated Exosomes, Exosome Characterization, Purification, Chromatography, Engineering, Targeted Delivery, Diagnostic Biomarker, and Quality Control), Method of Exosome Manufacturing (Engineering and Targeted Delivery), Scale of Operation (Discovery / Research, Pre-Clinical, Clinical or Commercialized) and Scalability (Small, Mid-Sized or large), Method of Isolation, Method of Purification, Method of Exosome Characterization, Industry Trends, and Global Forecasts, 2022-2035 And Segment Revenue and Forecast To 2031.

The AI Based Wound Care Software Market is estimated to exhibit a CAGR of 7.1% during the forecast period.

Download Free Report Sample Pages: https://www.insightaceanalytic.com/request-sample/2519

List of Prominent Players in the AI Based Wound Care Software Market:

• Pacify Medical
• Healogics
• Swift Medical
• Healthy.io
• WoundZoom
• eKare, Inc.
• Medline
• WoundMatrix
• Entec Solution
• Essity
• Spectral AI
• Urgo Medical

Buy 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/2519

Market Dynamics:

Drivers:

The growing incidence of chronic wounds, such as diabetic ulcers, pressure ulcers, and venous leg ulcers, necessitates advanced wound care solutions. Chronic wounds are often challenging to manage, requiring continuous monitoring and tailored treatment plans. AI-based solutions reduce the time and effort required for wound assessment and documentation, allowing healthcare providers to focus more on patient care. With an aging global population, the prevalence of conditions that lead to chronic wounds, such as diabetes and immobility, is on the rise. This demographic trend is driving the demand for innovative wound care technologies.

Challenges:

Healthcare providers face the challenge of justifying the cost of AI solutions in terms of improved patient outcomes and cost savings, a task made more difficult without comprehensive reimbursement policies. Additionally, patients in low-income regions may struggle to afford AI-driven wound care solutions, limiting their widespread adoption. Access to advanced healthcare technologies, including AI-based wound care software, is often restricted in rural and underserved areas due to a lack of infrastructure and resources. This digital divide further hampers the ability of these regions to benefit from the advancements in AI-driven healthcare, exacerbating existing disparities in health outcomes.

Regional Trends:

North America accounted for the largest share of the global wound care market, driven by a large patient population with chronic conditions like diabetes, a high incidence of surgical procedures, and a proactive approach to wound care focused on improving healthcare outcomes. This dominance can be attributed to the presence of advanced healthcare infrastructure, high adoption of digital healthcare technologies, and significant investments in research and development. Countries like the United States and Canada have well-established healthcare systems that prioritize innovation and technology integration. Additionally, the rising prevalence of chronic wounds, such as diabetic ulcers and pressure ulcers, in the region has propelled the demand for AI-based solutions for wound assessment, monitoring, and management.

Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2519

Recent Developments:

• In February 2024, Spectral AI, an artificial intelligence (AI) startup with a focus on medical diagnostics to enable quicker and more accurate treatment choices for wound care successfully obtained the last phase of UK Conformity Assessed (UKCA) authorization for DeepView AI-Burn, a predictive program intended to help with burn wound diagnosis in the United Kingdom.
• In November 2023, Urgo Medical, a well-known business that specializes in advanced wound care and imito AG, a knowledgeable supplier of wound care products, announced a collaboration meant to improve wound care. As a result of this partnership, imito AG’s WoundGenius automatic wound measurement technology was used by Urgo Medical to create a new feature called MEASURE in its wound app, Healico.

Segmentation of AI Based Wound Care Software Market

Global AI Based Wound Care Software Market – By Wound Type

• Chronic Wounds
  • Diabetic Ulcers
  • Pressure Ulcers
  • Venous Ulcers
• Acute Wounds
  • Traumatic Injuries
  • Surgical Wounds
  • Burns

Global AI Based Wound Care Software Market – By Application

• Wound Assessment and Monitoring
• Wound Healing Prediction
• Wound Documentation and Management
• Clinical Decision Support
• Others

North America–

• The US
• Canada
• Mexico

Europe–

• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific–

• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific

Latin America–

• Brazil
• Argentina
• Rest of Latin America

 Middle East & Africa–

• GCC Countries
• South Africa
• Rest of the Middle East and Africa